After more than two decades as a very successful and happy businesswoman, Jackie Gallant decided to retire as of 31st December, 2018. During her tenure as President, Jackie built a striving and highly respected autogenous biologics business serving Canada and growing her company from 1 to 15 employees.
In 2015, Gallant Custom Laboratories Inc. was purchased by IDT Biologika GmbH and they were very pleased that Jackie decided to stay for such a long time after the acquisition. She was instrumental in expanding the Canadian autogenous vaccine market, providing new vaccine ideas and opening the doors for IDTs commercial vaccines in Canada.
Jackie has smoothly handed over the “steering wheel” to Kalena Statutiak, who took over the role as President of Gallant Custom Laboratories Inc. By bringing Kalena on board, Jackie managed to identify a strong character to continue the company’s success story as a leading autogenous biologics company, and guide Gallant Custom Laboratories Inc. through new national and international ventures.